Pricing Log in Create free account
Friday 6 November 2026 Export MEDP’s income statement to Excel — free account

Medpace Holdings, Inc.

MEDP Healthcare Diagnostics & Research

Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.

Revenue
+8.50%
EPS
+24.6%
Free cash flow
−16.6%

Quarter to September 2026, against a year earlier

649.69 14.71 +2.32%
Market cap
$17.8B
P/E
34.6×
Fwd P/E
35.8×
Dividend yield
—
F-score
8/9
Altman Z
8.04
Beneish M
−2.92
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Medpace Holdings, Inc. (MEDP) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
10-Q Sep 30, 2026 P1I2: 1 added · 13 modified
P2I1A: no changes
8-K Oct 20, 2026 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jun 30, 2026
8-K Jul 22, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 1, 2026 5.02 Departure or appointment of directors or officers Officer departure
8-K May 15, 2026 5.03 Amendments to the articles or bylaws; change in fiscal year; 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026
8-K Apr 21, 2026 2.02 Results of operations and financial condition; 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 5 modified
1A: 1 added · 1 removed · 22 modified
7: 4 added · 10 removed · 32 modified
8-K Feb 9, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
8-K Oct 22, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
8-K Jul 17, 2025 1.01 Entry into a material definitive agreement; 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025
8-K Apr 17, 2025 1.01 Entry into a material definitive agreement; 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
10-K Dec 31, 2024
8-K Feb 6, 2025 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024
8-K Oct 21, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Jul 22, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 22, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 12, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.